These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 23788085

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
    Yasuda S, Miyazaki S, Kinoshita H, Nagaya N, Kanda M, Goto Y, Nonogi H.
    Clin Sci (Lond); 2007 Jan; 112(1):43-9. PubMed ID: 16939410
    [Abstract] [Full Text] [Related]

  • 45. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
    George J, Patal S, Wexler D, Roth A, Sheps D, Keren G.
    Am Heart J; 2005 Sep; 150(3):484-7. PubMed ID: 16169329
    [Abstract] [Full Text] [Related]

  • 46. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
    Cox DA, Stone GW, Grines CL, Stuckey T, Zimetbaum PJ, Tcheng JE, Turco M, Garcia E, Guagliumi G, Iwaoka RS, Mehran R, O'Neill WW, Lansky AJ, Griffin JJ, CADILLAC Investigators.
    Am J Cardiol; 2006 Aug 01; 98(3):331-7. PubMed ID: 16860018
    [Abstract] [Full Text] [Related]

  • 47. Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention.
    Ege M, Güray U, Güray Y, Yılmaz MB, Demirkan B, Saşmaz A, Korkmaz S.
    Anadolu Kardiyol Derg; 2011 May 01; 11(3):213-7. PubMed ID: 21421510
    [Abstract] [Full Text] [Related]

  • 48. Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Ørn S, Ueland T, Manhenke C, Sandanger Ø, Godang K, Yndestad A, Mollnes TE, Dickstein K, Aukrust P.
    J Intern Med; 2012 Sep 01; 272(3):267-76. PubMed ID: 22243053
    [Abstract] [Full Text] [Related]

  • 49. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH, Jin XF, Fang Q, Zhang SY, Shen ZJ, Fan ZJ, Liu ZY, Xie HZ.
    Zhonghua Yi Xue Za Zhi; 2011 Nov 15; 91(42):3003-6. PubMed ID: 22333029
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. NT pro-B-type natriuretic peptide levels are related to microvascular reperfusion in patients undergoing direct percutaneous transluminal coronary angioplasty for anterior ST-segment elevation myocardial infarction.
    Rossetti E, Mariani M, Poli A, Palmerini T, Finazzi S, Lotzniker M, Sangiorgi D, De Servi S.
    J Cardiovasc Med (Hagerstown); 2010 May 15; 11(5):359-64. PubMed ID: 20051875
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry).
    Rakowski T, Siudak Z, Dziewierz A, Birkemeyer R, Janzon M, Mielecki W, Zmudka K, Dubiel JS, Dudek D.
    Kardiol Pol; 2012 May 15; 70(3):215-21. PubMed ID: 22430397
    [Abstract] [Full Text] [Related]

  • 54. [Effect of percutaneous coronary intervention timing and cilostazol use on left ventricular remodeling in patients with non-ST elevation myocardial infarction].
    Wang SL, Sun F, Zhao X, Chen LL, Feng GB, Yan CH, Han YL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Oct 15; 38(10):870-4. PubMed ID: 21176627
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.
    Yan AT, Yan RT, Spinale FG, Afzal R, Gunasinghe HR, Arnold M, Demers C, McKelvie RS, Liu PP.
    J Card Fail; 2006 Sep 15; 12(7):514-9. PubMed ID: 16952784
    [Abstract] [Full Text] [Related]

  • 57. MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy.
    Opstad TB, Seljeflot I, Bøhmer E, Arnesen H, Halvorsen S.
    Cardiology; 2018 Sep 15; 139(1):17-24. PubMed ID: 29141241
    [Abstract] [Full Text] [Related]

  • 58. Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction.
    Kwon JS, Kim YS, Cho AS, Cho HH, Kim JS, Hong MH, Jeong HY, Kang WS, Hwang KK, Bae JW, Jeong MH, Cho MC, Ahn Y.
    Life Sci; 2014 Apr 17; 101(1-2):15-26. PubMed ID: 24560960
    [Abstract] [Full Text] [Related]

  • 59. The relationship between markers of extracellular cardiac matrix turnover: infarct healing and left ventricular remodelling following primary PCI in patients with first-time STEMI.
    Manhenke C, Ueland T, Jugdutt BI, Godang K, Aukrust P, Dickstein K, Ørn S.
    Eur Heart J; 2014 Feb 17; 35(6):395-402. PubMed ID: 24255130
    [Abstract] [Full Text] [Related]

  • 60. ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis.
    Stolfo D, Cinquetti M, Merlo M, Santangelo S, Barbati G, Alonge M, Vitrella G, Rakar S, Salvi A, Perkan A, Sinagra G.
    Int J Cardiol; 2016 Jul 15; 215():340-5. PubMed ID: 27128558
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.